Diabetes Mellitus, Type 1
Showing NaN - NaN of 43
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Escondido, San Antonio, Renton (Continuous Glucose Monitoring System)
Recruiting
- Diabetes Mellitus
- +2 more
- Continuous Glucose Monitoring System
-
Escondido, California
- +2 more
May 11, 2022
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Eversense® CGM system)
Active, not recruiting
- Diabetes Mellitus
- +2 more
- Eversense® CGM system
-
Newport Beach, California
- +16 more
Mar 31, 2022
Diabetes, Type 1 Trial in United States (MYL-1601D Product, FlexPen NovoLog®)
Completed
- Diabetes Mellitus, Type 1
- MYL-1601D Product
- FlexPen NovoLog®
-
Montgomery, Alabama
- +157 more
Feb 23, 2022
Diabetes, Type 1 Diabetes, Diabetes, Type 1 Trial in United States (Bionic Pancreas)
Completed
- Diabetes Mellitus
- +2 more
- Bionic Pancreas
-
Orange, California
- +15 more
Jan 17, 2022
A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
-
San Antonio, Texas(unnamed)
May 12, 2021
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Continuous Glucose Monitoring System)
Completed
- Diabetes Mellitus
- +2 more
- Continuous Glucose Monitoring System
-
Concord, California
- +7 more
Mar 30, 2021
Diabetes, Type 1 Trial in United States (TOL-3021, TOL-3021 Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 1
- TOL-3021
- TOL-3021 Placebo
-
San Diego, California
- +22 more
Nov 5, 2020
Diabetes, Type 1 Trial in Worldwide (Gan & Lee Insulin Glargine Injection, Lantus®)
Completed
- Diabetes Mellitus, Type 1
- Gan & Lee Insulin Glargine Injection
- Lantus®
-
Birmingham, Alabama
- +84 more
Jul 7, 2020
Diabetes, Type 1, Insulin-dependent Diabetes Trial in San Antonio (PRAM9, Regular Insulin + Pramlintide, Regular Insulin)
Completed
- Diabetes Mellitus, Type 1
- Insulin-dependent Diabetes Mellitus
- PRAM9
- +2 more
-
San Antonio, TexasWorld Wide Clinical Trials
May 27, 2020
Diabetes, Type 1 Trial in Worldwide (Gan & Lee Insulin Lispro Injection, Humalog)
Withdrawn
- Diabetes Mellitus, Type 1
- Gan & Lee Insulin Lispro Injection
- Humalog
-
Anaheim, California
- +106 more
Feb 2, 2020
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Little Rock, Arkansas
- +80 more
Jun 3, 2019
Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- Insulin lispro
- +4 more
-
Escondido, California
- +18 more
Feb 5, 2019
Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Birmingham, Alabama
- +98 more
Dec 7, 2018
Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 1
- Empagliflozin
- Placebo
-
Montgomery, Alabama
- +188 more
Oct 31, 2018
Hypoglycemia, Diabetes, Type 1 Trial in Canada, United States (G-Pen (glucagon injection), Lilly Glucagon (glucagon injection
Completed
- Hypoglycemia
- Diabetes Mellitus, Type 1
- G-Pen (glucagon injection)
- Lilly Glucagon (glucagon injection [rDNA origin])
-
Birmingham, Alabama
- +6 more
Sep 29, 2018
Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
- +2 more
-
Birmingham, Alabama
- +95 more
Sep 3, 2018
Diabetes, Type 1 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable insulin, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 1
- Human Insulin Inhalation Powder
- +2 more
-
Aurora, Colorado
- +36 more
Mar 7, 2018
Diabetes, Type 1 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable Insulin, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 1
- Human Insulin Inhalation Powder
- +2 more
-
Sacramento, California
- +60 more
Mar 7, 2018
Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Abbott Sensor Based Glucose Monitoring System)
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Abbott Sensor Based Glucose Monitoring System
-
Santa Barbara, California
- +5 more
Jan 22, 2018
Diabetes, Type 1 Trial in Canada, United States (Otelixizumab)
Terminated
- Diabetes Mellitus, Type 1
-
Birmingham, Alabama
- +16 more
Oct 11, 2017
Diabetes, Type 1 Trial in Worldwide (otelixizumab infusion plus physician determined standard of care, infusion plus physician
Completed
- Diabetes Mellitus, Type 1
- otelixizumab infusion plus physician determined standard of care
- placebo infusion plus physician determined standard of care
-
Birmingham, Alabama
- +108 more
Sep 5, 2017
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (FlexTouch®, FlexPen®)
Completed
- Diabetes
- +3 more
- FlexTouch®
- FlexPen®
-
Burlingame, California
- +64 more
Feb 6, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec/insulin aspart
- +2 more
-
La Mesa, California
- +80 more
Feb 9, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin detemir
- +2 more
-
Anaheim, California
- +80 more
Jan 26, 2017
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (NovoFine® needle 6 mm, Ultra-Fine needle 12.7 mm)
Completed
- Diabetes
- +3 more
- NovoFine® needle 6 mm
- Ultra-Fine needle 12.7 mm
-
Walnut Creek, California
- +4 more
Jan 18, 2017